People undergoing hemodialysis treatment for kidney failure often experience chronic pain related to their condition, but it ...
Hosted on MSN1d
New FDA Approval Could Transform Pain ManagementIt’s become a familiar tragedy: someone is prescribed pain medication to recover from an injury, then becomes addicted to the medication intended to improve their life. It’s left both healthcare ...
The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.
A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug ...
The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under the brand name Journavx.
The drug, Journavx, from Vertex Pharmaceuticals, reduced pain after surgery in clinical trials. Experts hope it can lead to fewer opioid prescriptions.
U.S.-based Vertex Pharmaceuticals (VRTX) has secured approval from the FDA (Food and Drug Administration) for its ...
The Vertex drug is a milestone after a long history of unsuccessful efforts to develop painkillers without the addictive ...
Today, the U.S. Food and Drug Administration approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class ...
The US Food and Drug Administration signed off Thursday on the first new type of pain reliever to be approved in more than ...
Research on pain in preterm infants shows frequent painful procedures and inadequate pain management, emphasizing the need for better assessment strategies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback